HEXO (HEXO), which has a partnership with Molson Coors, rose almost 5.4% on October 15 to 8.95 Canadian dollars. The company was formerly known as Hydropothecary and is one of the five cannabis companies (HMMJ) besides Canopy Growth (CGC) (WEED), Tilray (TLRY), and Aphria (APHQFM) to secure a supply agreement with the province of Quebec. Let’s look at analysts’ recommendation and price target for the stock below.
In the current month, the overall consensus recommendation on HEXO is a “buy,” which remained unchanged from September. Two analysts continued to have a “strong buy” recommendation on the company, while five analysts maintained a “buy” recommendation on the stock.
The current consensus price target on HEXO in October stood at 8.7 Canadian dollars, which increased slightly from 8.6 Canadian dollars in September. The median price target, however, increased more than 8.9% month-over-month to 8.5 Canadian dollars from 7.8 Canadian dollars. With a close of 8.95 Canadian dollars on October 15, the mean price target of 8.7 Canadian dollars was about 3% lower, indicating that the market is more optimistic than the consensus analyst target.
Tilray (TLRY) stock gained ~11.7% on October 15 to $165 per share.
Mondelēz (MDLZ) is scheduled to announce its first-quarter earnings results on April 30.
Freeport-McMoRan (FCX) is scheduled to release its first-quarter earnings on April 25.
Ford has risen 8.2% in April so far as compared to 2.6% gains in the S&P 500 Index.
On April 22, natural gas prices settled at $2.52 per MMBtu—1.4% above the lowest closing level for active natural gas futures since June 8, 2016.
Kimberly-Clark (KMB) stock rose 5.4% on April 22 after the company released stronger-than-expected first-quarter results.
Alaska Air Group (ALK) plans to report its first-quarter earnings results on April 25.